Clinical Efficacy of Ianalumab in Sjögren’s Disease: Mixed Results Raise Regulatory Hurdles
By John Gever, Contributing Writer, MedPage Today October 21, 2026 The quest for a definitive therapeutic breakthrough in Sjögren’s disease has hit a significant roadblock. Recent publication of findings from…












